CVE-2026-34323: Vulnerability in the Oracle Life Sciences InForm product of Oracle Life Science Applications (component: IDM Authentication). Supported versions that...

Description

Vulnerability in the Oracle Life Sciences InForm product of Oracle Life Science Applications (component: IDM Authentication). Supported versions that are affected are 7.0.1.0 and 7.0.1.1. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks require human interaction from a person other than the attacker. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences InForm accessible data as well as unauthorized read access to a subset of Oracle Life Sciences InForm accessible data and unauthorized ability to cause a partial denial of service (partial DOS) of Oracle Life Sciences InForm. CVSS 3.1 Base Score 6.3 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:L).

Metrics

CVSS 3.1

6.3/10

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:L

EPSS Probability

0.18%

7.3th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

CWE-284

Affected Software

Vendor	Product	Versions
Oracle	Life Sciences Inform	7.0.1.0
Oracle	Life Sciences Inform	7.0.1.1

References

https://www.oracle.com/security-alerts/cpuapr2026.htmlVendor Advisory

Timeline

Published: Apr 21, 2026
Last Modified: Jun 17, 2026
Status: Analyzed

Frequently Asked Questions

What is CVE-2026-34323?

Vulnerability in the Oracle Life Sciences InForm product of Oracle Life Science Applications (component: IDM Authentication). Supported versions that are affected are 7.0.1.0 and 7.0.1.1. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks require human interaction from a person other than the attacker. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences InForm accessible data as well as unauthorized read access to a subset of Oracle Life Sciences InForm accessible data and unauthorized ability to cause a partial denial of service (partial DOS) of Oracle Life Sciences InForm. CVSS 3.1 Base Score 6.3 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:L).

How severe is CVE-2026-34323?

CVE-2026-34323 has a CVSS score of 6.3/10 (MEDIUM severity). The EPSS model estimates a 0.18% probability of exploitation in the next 30 days.

How do I fix CVE-2026-34323?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.